Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.400
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $67.6 million as of March 5, 2026. Its market cap has increased by 178.98% in one year.
Market Cap
67.60M
Enterprise Value
67.20M
Revenue
2.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.40
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 67.60M, an increase of 240.48%. That is a compound annual growth rate of 14.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 67.60M | -28.78% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 180.09M |
| BioStem Technologies | 90.09M |
| HST Global | 70.56M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |
| Arch Biopartners | 38.49M |
| ZIVO Bioscience | 37.00M |
| Harvard Apparatus Regenerative Technology | 31.12M |